Copyright
©The Author(s) 2020.
World J Hepatol. Aug 27, 2020; 12(8): 451-474
Published online Aug 27, 2020. doi: 10.4254/wjh.v12.i8.451
Published online Aug 27, 2020. doi: 10.4254/wjh.v12.i8.451
Figure 5 The proposed treatment algorithm for sepsis in cirrhosis[66,68,70-72,75].
BCAA: Branched-chain amino acids; FMT: Faecal microbiota transplantation; G-CSF: Granulocyte-colony stimulating factor; GM: Granulocyte-macrophage; ICU: Intensive care unit; IMRT: Intestinal microbiota re-instituition therapy; IV: Intravenous; LOLA: L-ornitine L-aspartate; LPS: Lipopolysaccharide; MDR: Multidrug resistant.
- Citation: Philips CA, Ahamed R, Rajesh S, George T, Mohanan M, Augustine P. Update on diagnosis and management of sepsis in cirrhosis: Current advances. World J Hepatol 2020; 12(8): 451-474
- URL: https://www.wjgnet.com/1948-5182/full/v12/i8/451.htm
- DOI: https://dx.doi.org/10.4254/wjh.v12.i8.451